Challenges in CNS drug development and the role of imaging
- PMID: 33860824
- DOI: 10.1007/s00213-021-05838-3
Challenges in CNS drug development and the role of imaging
Comment on
-
Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology.Psychopharmacology (Berl). 2021 Jun;238(6):1417-1436. doi: 10.1007/s00213-021-05787-x. Epub 2021 Mar 10. Psychopharmacology (Berl). 2021. PMID: 33694032 Free PMC article. Review.
References
-
- Blest-Hopley G, O’Neill A, Wilson R, Giampietro V, Bhattacharyya S (2021) https://doi.org/10.1007/s00213-019-05407-9
-
- Egerton A (2021) https://doi.org/10.1007/s00213-019-05344-7
-
- Gilleen J, Farah Y, Davison C, Kerins S, Valdearenas L, Uz T, Lahu G, Tsai M, Ogrinc F, Reichenberg A, Williams SC, Mehta MA, Shergill SS (2021) https://doi.org/10.1007/s00213-018-5134-y
-
- Godlewska BR, Harmer CJ (2021) https://doi.org/10.1007/s00213-019-05448-0
-
- Grimm O, Nägele M, Küpper-Tetzel L, de Greck M, Plichta M, Reif A (2021) https://doi.org/10.1007/s00213-020-05693-8
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources